Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04705909 | Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Mansoura UniversityOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT04665986 | Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer | unknown | Phase 3 | 50 | Zhejiang Cancer HospitalOTHER | 0 | Dec 14, 2020 | clinicaltrials |
| Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer. |
| unknown |
| Phase 2 / Phase 3 |
| 120 |
| Mansoura UniversityOTHER |
| 1 |
| Jun 11, 2020 |
| clinicaltrials |
| NCT04403529 | Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT04405505 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) | unknown | Phase 3 | 332 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT04337658 | Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer(FAVOR) | unknown | Phase 3 | 493 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | unknown | Phase 3 | 290 | RenJi HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04307147 | NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy | unknown | Phase 3 | 316 | Fudan UniversityOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT01758146 | Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors | unknown | Phase 3 | 412 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00541086 | Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery | unknown | Phase 3 | 3,697 | Gruppo Italiano Mammella (GIM)OTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases(CORE) | unknown | Phase 2 / Phase 3 | 245 | Royal Marsden NHS Foundation TrustOTHER | 2 | Aug 21, 2019 | clinicaltrials |
| NCT01907529 | A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer(TENDENCY) | unknown | Phase 2 / Phase 3 | 300 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 9, 2019 | clinicaltrials |
| NCT04046159 | Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ | unknown | Phase 3 | 810 | National Taiwan University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT03544762 | Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation(breast) | unknown | Phase 3 | 60 | National Taiwan University HospitalOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT03876886 | The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT00532727 | Triple Negative Breast Cancer Trial(TNT) | unknown | Phase 3 | 400 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT03731026 | The LightPath® and 68Ga-RM2 in Breast Cancer Study | unknown | Phase 3 | 80 | Lightpoint Medical LimitedINDUSTRY | 1 | Nov 6, 2018 | clinicaltrials |
| NCT03696004 | Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt | unknown | Phase 2 / Phase 3 | 45 | Assiut UniversityOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer(EPHOS-B) | unknown | Phase 3 | 257 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery(TACT2) | unknown | Phase 3 | 4,400 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02898376 | Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer(FIBROTHERME) | unknown | Phase 3 | 142 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03566394 | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 46 | British Columbia Cancer AgencyOTHER | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03518957 | 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers | unknown | Phase 3 | 304 | National University Hospital, SingaporeOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT03507465 | Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer | unknown | Phase 2 / Phase 3 | 290 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | unknown | Phase 2 / Phase 3 | 60 | Centro Hospitalar Lisboa OcidentalOTHER_GOV | 0 | Apr 9, 2018 | clinicaltrials |
| NCT03423849 | The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Feb 6, 2018 | clinicaltrials |
| NCT03404752 | Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. | unknown | Phase 3 | 120 | Gema Biotech S.A.INDUSTRY | 1 | Jan 19, 2018 | clinicaltrials |
| NCT03373708 | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Dec 18, 2017 | clinicaltrials |
| NCT03349177 | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03319069 | Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer | unknown | Phase 3 | 60 | Ahmed AhmOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT00408408 | Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery | unknown | Phase 3 | 1,206 | NSABP Foundation IncNETWORK | 3 | Sep 18, 2017 | clinicaltrials |
| NCT03085368 | A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin | unknown | Phase 2 / Phase 3 | 482 | Peking Union Medical College HospitalOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients(NNBC3-Europe) | unknown | Phase 3 | 4,150 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT02761460 | The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia | unknown | Phase 3 | 338 | wang shusenOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | unknown | Phase 3 | 636 | China Breast Cancer Clinical Study GroupOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT03006614 | PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer(PERS) | unknown | Phase 3 | 320 | Shi YanxiaOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | unknown | Phase 3 | 100 | Shandong Cancer Hospital and InstituteOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02830685 | Pre-pectoral Breast Reconstruction PART 1(PreBRec) | unknown | Phase 3 | 131 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT02831426 | Pre-pectoral Breast Reconstruction PART 2(PreBRec) | unknown | Phase 3 | 86 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT02865304 | The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | unknown | Phase 3 | 80 | Fujian Cancer HospitalOTHER_GOV | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02802826 | Studying Tailored Exercise Prescriptions in Breast Cancer Patients(STEPS) | unknown | Phase 3 | 100 | Loughborough UniversityOTHER | 1 | Jun 16, 2016 | clinicaltrials |
| NCT02383030 | Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients(FUMANCE) | unknown | Phase 3 | 156 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02394496 | Overcoming Endocrine Resistance in Metastatic Breast Cancer(OVER) | unknown | Phase 3 | 396 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02404051 | Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer(FEVEX) | unknown | Phase 3 | 745 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | unknown | Phase 3 | 529 | NSABP Foundation IncNETWORK | 3 | Jun 6, 2016 | clinicaltrials |
| NCT02690636 | Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer | unknown | Phase 3 | 500 | Ain Shams UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02097459 | Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer | unknown | Phase 3 | 600 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT00402519 | APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer | unknown | Phase 3 | 1,300 | University of Erlangen-Nürnberg Medical SchoolOTHER | 5 | May 13, 2016 | clinicaltrials |
| NCT02207335 | Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer | unknown | Phase 3 | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02595138 | Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer | unknown | Phase 3 | 430 | Chinese Academy of Medical SciencesOTHER | 0 | Nov 3, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Jan 12, 2021source: clinicaltrials